StockData
Scilex Holding Co logo

Scilex Holding Co (SCLXW) stock

SCLXWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as SCLX
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$0.04−0.00 (-1.53%)

Close on Oct 30, 2026Market cap $17.50MP/E –Yield –

Scilex gross margin

Gross margin is gross profit as a percentage of revenue.

Scilex's gross margin for the twelve months ending Jun 30, 2026 was 161.1%. For fiscal 2025 it was 415.8%, against 295.8% the year before. The highest annual figure on record is 415.8% in fiscal 2025.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025415.8%+120.0
FY2024Dec 31, 2024295.8%+229.4
FY2023Dec 31, 202366.5%−5.2
FY2022Dec 31, 202271.6%−16.8
FY2021Dec 31, 202188.4%−2.5
FY2020Dec 31, 202090.9%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026206.8%−192.4
Q1 FY2026Mar 31, 2026298.4%−55.3
Q4 FY2025Dec 31, 202545.5%−23.1
Q3 FY2025Sep 30, 202568.5%−5.4
Q2 FY2025Jun 30, 2025399.2%+326.0
Q1 FY2025Mar 31, 2025353.7%+289.0
Q4 FY2024Dec 31, 202468.5%+2.1
Q3 FY2024Sep 30, 202473.9%+7.4
Q2 FY2024Jun 30, 202473.2%+6.4
Q1 FY2024Mar 31, 202464.7%−1.3
Q4 FY2023Dec 31, 202366.4%+4.3
Q3 FY2023Sep 30, 202366.5%−1.8
Q2 FY2023Jun 30, 202366.8%−13.9
Q1 FY2023Mar 31, 202366.1%−17.1
Q4 FY2022Dec 31, 202262.1%–
Q3 FY2022Sep 30, 202268.3%–
Q2 FY2022Jun 30, 202280.7%–
Q1 FY2022Mar 31, 202283.2%–

More Scilex figures